Prospect Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Prospect Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Hold	1,606	–	–	0.13%	96
2026 Q1	$205K	Buy	+1,606	New	+$200K	0.13%	100
2025 Q1	–	Sell	-2,451	Closed	-$221K	–	124
2024 Q4	$221K	Hold	2,451	–	–	0.12%	105
2024 Q3	$242K	Sell	2,451 -250	-9%	-$24.6K	0.15%	90
2024 Q2	$250K	Hold	2,701	–	–	0.19%	66
2024 Q1	$256K	Buy	2,701 +230	+9%	+$21.3K	0.21%	64
2023 Q4	$221K	Buy	+2,471	New	+$184K	0.22%	64

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Prospect Financial Services's XBI Position: Q2 2026 in Review

Prospect Financial Services held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 1,606 shares worth $254K. The position accounts for 0.13% of the portfolio, ranked #96.

Prospect Financial Services first reported a position in XBI in Q4 2023 and has held it in 7 quarters since. The position peaked at $256K in Q1 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Prospect Financial Services held 1,606 shares of State Street SPDR S&P Biotech ETF worth $254K as of Q2 2026.
Prospect Financial Services left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.13% of Prospect Financial Services's portfolio in Q2 2026, its #96 holding.
Prospect Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 7 quarters since.
Prospect Financial Services's State Street SPDR S&P Biotech ETF position peaked at $256K in Q1 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Prospect Financial Services's 13F filing for Q2 2026, filed 6 Aug 2026.